ロード中...

Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.

In normal plasma, the serine protease inhibitor alpha 1-antitrypsin (alpha 1-AT) plays little or no role in the control of plasma kallikrein or activated Factor XII fragment (Factor XIIf), this function being performed by Cl-inhibitor. Recently, an alpha 1-AT variant was described with a Met----Arg...

詳細記述

保存先:
書誌詳細
出版年:J Clin Invest
主要な著者: Schapira, M, Ramus, M A, Jallat, S, Carvallo, D, Courtney, M
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Clinical Investigation 1986
主題:
オンライン・アクセス:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423402/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3484756/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112347
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!